Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $159.8 million.

  • Resmed's Non-Current Deffered Revenue rose 906.21% to $159.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $159.8 million, marking a year-over-year increase of 906.21%. This contributed to the annual value of $156.8 million for FY2025, which is 1416.89% up from last year.
  • Resmed's Non-Current Deffered Revenue amounted to $159.8 million in Q4 2025, which was up 906.21% from $159.4 million recorded in Q3 2025.
  • Resmed's Non-Current Deffered Revenue's 5-year high stood at $159.8 million during Q4 2025, with a 5-year trough of $86.9 million in Q1 2021.
  • For the 5-year period, Resmed's Non-Current Deffered Revenue averaged around $121.0 million, with its median value being $120.3 million (2023).
  • As far as peak fluctuations go, Resmed's Non-Current Deffered Revenue surged by 269.81% in 2021, and later surged by 2486.09% in 2023.
  • Over the past 5 years, Resmed's Non-Current Deffered Revenue (Quarter) stood at $94.4 million in 2021, then increased by 8.87% to $102.8 million in 2022, then increased by 23.94% to $127.4 million in 2023, then grew by 14.99% to $146.5 million in 2024, then rose by 9.06% to $159.8 million in 2025.
  • Its last three reported values are $159.8 million in Q4 2025, $159.4 million for Q3 2025, and $156.8 million during Q2 2025.